SurgiMab
Model SGM-101 - Tumor-Specific Antibody
FromSurgiMab
SGM-101, currently in Phase III for the delineation of primary and recurrent tumor and metastases in patients undergoing surgery for colorectal cancer, is a tumor-specific antibody conjugated to a near-infrared fluorochrome. It selectively binds a specific marker overexpressed in gastrointestinal and other tumors.
Most popular related searches
tumor specificity
ovarian cancer
surgery outcome
colorectal cancer
surgery
preclinical product
surgery visualization
targeted cancer surgery
cancerous tumor
tumor detection
SGM-201 is a preclinical stage product based on the same technique that targets ovarian cancer. Both allow surgeons to visualize tumors in real-time with a near-infrared camera, helping them to perform more radical cytoreductive surgery, thus automatically improving surgical outcomes.
